Kerala Ayurveda P/B Ratio
Kerala Ayurveda (KERALAYUR) P/B ratio is 22.26 (High), book value per share ₹8.46 vs Healthcare average P/B of -0.35 — Very High - Significant premium, high growth expectations or speculative. View KERALAYUR 52-week chart for the annual high/low range and current price position.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
KERALAYUR P/B Ratio — Valuation Insights & Book Value Analysis
Kerala Ayurveda price-to-book ratio interpretation, valuation status and historical context — current P/B 22.26 (High). For live price, earnings yield and the full fundamental profile, see Kerala Ayurveda share price today.
- Stock appears overvalued with PB of 22.26, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Trading at premium to sector average PB of -0.35
Kerala Ayurveda P/B Ratio Historical Trend
KERALAYUR annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Compare with KERALAYUR fair value estimate to assess whether the stock is under or overvalued.
KERALAYUR Historical P/B Ratio — Book Value Per Share & Year-End Price
Kerala Ayurveda annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 22.46 | ₹8.46 | ₹190.05 | ₹11 | High |
| 2025 | 29.15 | ₹10.83 | ₹315.75 | ₹13 | High |
| 2024 | 25.18 | ₹17.5 | ₹440.70 | ₹21 | High |
| 2023 | 36.68 | ₹7.27 | ₹266.75 | ₹8 | High |
| 2022 | 14.55 | ₹7.27 | ₹105.80 | ₹8 | High |
KERALAYUR vs Healthcare Peers — P/B Ratio Comparison
Kerala Ayurveda P/B 22.26 vs Healthcare average -0.35, median 0.61 — range -18.41–1.04.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -18.41 | ₹23 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Parmax Pharma | PARMAX | -3.24 | ₹23 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.86 | ₹142 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.6 | ₹53 | Low |